Sripen Tantivess BSc, MPH, PhD* * Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand This paper presents a review of the domestic and international literature on the assessment of the social and ethical implications of health technologies. It g

Welcome to iDSI, the international Decision Support Initiative. We provide a platform for supporting low and middle income country (LMIC) policymakers in making better use of healthcare resources to generate maximum health, in their journeys towards universal health coverage (UHC).

Since its inception, health technology assessment (HTA) has assisted governments across the world through evidence-informed health resources allocation and it all begins at the Office of Technology Assessment (OTA), United States Congress led by Dr. David Banta.This video is a tribute to Dr. David B

Vietnam is one of the countries that are on the journey to achieve Universal Health Coverage (UHC). With the Health Insurance Law enacted in 2008, and master plan for UHC approved by the prime minister in 2013 addressing some important issues including prioritizing healthcare provided to the populat

The term “global health” has emerged as part of the larger political and historical process, replacing the term “international health” to imply a shared global responsibility for health. The General Assembly of the United Nations highlighted the relations of “Global health and foreign policy and ind

ID modelling is a mathematical description of the spread of infection (1). Infectious disease (ID) in this study refers to common infectious diseases (whether in humans or animals), including COVID-19. ID models help provide the understanding of the disease natural history, as well as the impact of interventions (e.g., vaccination, social distancin

Executive Summary Digital health technology (DHT) offers the potential to expand universal health coverage (UHC) by answering healthcare needs through a wide range of technology applications for instance artificial intelligence, big data, and machine learning. The adoption of DHT is not a new con

From 23rd to 25th February 2018, three members from HITAP’s International Unit (HIU) went to Chandigarh, India. Two separate events occurred in Chandigarh during this time. The first was the 7th International Fellowship on Health Technology Assessment, a week-long HTA training workshop from 19th to

This report summarizes the sessions in the Medicines Pricing, Reimbursement Policy, and Benefits Package for Medicines in Thailand study visit, held on 4 – 8 March 2024 in Nonthaburi, Thailand. This study visit was organized by the Health Intervention and Technology Assessment Program (HITAP) under

K. Chittawatanarat a, *, K. Tosanguan b, U. Chaikledkaew b, c, S. Tejavanija d, Y. Teerawattananon b a Division of Trauma and Critical Care, Department of Surgery, Faculty of Medicine, Maharaj Nakorn Chiang Mai Hospital, Intawarorod Road, Sripume, Chiang Mai University, Chiang Mai 50200, Thailand